Claudette E. Loo

University of California, Los Angeles — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

43h-index6.0kcitations150works5.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Breast Cancer Treatment Studies(78), MRI in cancer diagnosis(48), Breast Lesions and Carcinomas(47), Radiomics and Machine Learning in Medical Imaging(45), Medical Imaging Techniques and Applications(35)

Publications149 total

TMET-40. Proneural Glioblastomas Exhibit Altered Lipid Metabolism That Promotes Susceptibility to Non-Canonical Cell Death
Neuro-Oncology·2025Open Access
Associations between adipocyte hypertrophy and epithelium-to-stroma proportion with clinicopathologic and epidemiologic factors in women with ductal carcinoma in situ
2025Open Access
Iodine Seed−Marking Protocol for Response-Guided Axillary Treatment After Systemic Therapy for Node-Positive Breast Cancer
JAMA Oncology·2025· 4 citedOpen Access
193MO Predictive value of FDG-PET/CT and MRI for neoadjuvant immunotherapy (IO) response in early-stage triple-negative breast cancer (eTNBC): Exploratory analysis of the phase II BELLINI trial
ESMO Open·2025Open Access
Multireader Diagnostic Accuracy of Abbreviated Breast MRI for Screening Women with Extremely Dense Breasts
Radiology·2025· 3 citedOpen Access
Omitting axillary lymph node dissection in breast cancer patients with extensive nodal disease and excellent response to primary systemic therapy using the MARI protocol
The Breast·2025· 11 citedOpen Access
Supine Versus Prone: A Comparison of Percutaneous Nephrolithotomy Outcomes in Obese Patients
Open Journal of Urology·2025Open Access
High-impact complications after breast cancer surgery in the Dutch national quality registry: evaluating case-mix adjustment for hospital comparisons
BJS Open·2024· 4 citedOpen Access
TMET-37. TARGETING LIPID MEDIATED NON-CANONICAL CELL DEATH IN MALIGNANT GLIOMA
Neuro-Oncology·2024Open Access
The efficacy of screening with FDG-PET/CT for distant metastases in breast cancer patients scheduled for neoadjuvant systemic therapy
Breast Cancer Research and Treatment·2024Open Access
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial
Nature Medicine·2024· 46 citedOpen Access
LBA11 Neoadjuvant nivolumab/relatlimab or nivolumab/ipilimumab in triple negative breast cancer with high tumor-infiltrating lymphocytes (TILs)
Annals of Oncology·2024· 6 citedOpen Access
Clinical implications of non-breast cancer related findings on FDG-PET/CT scan prior to neoadjuvant chemotherapy in patients with breast cancer
Breast Cancer Research and Treatment·2024Open Access
Intraoperative near infrared functional imaging of rectal cancer using artificial intelligence methods - now and near future state of the art
European Journal of Nuclear Medicine and Molecular Imaging·2024· 16 citedOpen Access
Oncologic outcome of response-guided axillary treatment in patients with cN1 breast cancer after primary systemic therapy.
Journal of Clinical Oncology·2024· 1 cited
Re-attendance in supplemental breast MRI screening rounds of the DENSE trial for women with extremely dense breasts
European Radiology·2024· 4 citedOpen Access
Radiological, pathological and surgical outcomes after neoadjuvant endocrine treatment in patients with ER-positive/HER2-negative breast cancer with a clinical high risk and a low-risk 70-gene signature
The Breast·2024· 5 citedOpen Access
Omission of axillary lymph node dissection in cN2-3 breast cancer patients with an excellent response on primary systemic treatment is safe: 4-year oncologic outcome of the MARI protocol
European Journal of Cancer·2024· 1 citedOpen Access
Breast surgery after neoadjuvant chemotherapy in patients with lobular carcinoma: surgical and oncologic outcome
Breast Cancer Research and Treatment·2024· 3 cited
Clinicopathological and prognostic value of calcification morphology descriptors in ductal carcinoma in situ of the breast: a systematic review and meta-analysis
Insights into Imaging·2023· 8 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Emiel J. Rutgers(24), Jelle Wesseling(16), Kenneth G. A. Gilhuijs(16), Marie-Jeanne T. F. D. Vrancken Peeters(15), Ritse M. Mann(10), Gabe S. Sonke(10), Marc B. I. Lobbes(8), Harry J. de Koning(8), Frederieke van Duijnhoven(8), Ruud M. Pijnappel(6), Katya M. Duvivier(6), Jeroen Veltman(6), Nico Karssemeijer(6), Maurice A. A. J. van den Bosch(6), Wouter B. Veldhuis(6), Marieke E. Straver(6), Sjoerd Rodenhuis(6), Sara Müller(6), Renato A. Valdés Olmos(6), Willem P.Th.M. Mali(5)